1. Home
  2. CSBR vs FOSL Comparison

CSBR vs FOSL Comparison

Compare CSBR & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • FOSL
  • Stock Information
  • Founded
  • CSBR 1985
  • FOSL 1984
  • Country
  • CSBR United States
  • FOSL United States
  • Employees
  • CSBR N/A
  • FOSL N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • FOSL Consumer Specialties
  • Sector
  • CSBR Health Care
  • FOSL Consumer Discretionary
  • Exchange
  • CSBR Nasdaq
  • FOSL Nasdaq
  • Market Cap
  • CSBR 65.9M
  • FOSL 55.3M
  • IPO Year
  • CSBR 1986
  • FOSL 1993
  • Fundamental
  • Price
  • CSBR $4.44
  • FOSL $1.15
  • Analyst Decision
  • CSBR Strong Buy
  • FOSL
  • Analyst Count
  • CSBR 1
  • FOSL 0
  • Target Price
  • CSBR $6.00
  • FOSL N/A
  • AVG Volume (30 Days)
  • CSBR 11.4K
  • FOSL 432.2K
  • Earning Date
  • CSBR 12-10-2024
  • FOSL 11-07-2024
  • Dividend Yield
  • CSBR N/A
  • FOSL N/A
  • EPS Growth
  • CSBR N/A
  • FOSL N/A
  • EPS
  • CSBR N/A
  • FOSL N/A
  • Revenue
  • CSBR $51,655,000.00
  • FOSL $1,223,954,000.00
  • Revenue This Year
  • CSBR $9.27
  • FOSL N/A
  • Revenue Next Year
  • CSBR $9.76
  • FOSL N/A
  • P/E Ratio
  • CSBR N/A
  • FOSL N/A
  • Revenue Growth
  • CSBR N/A
  • FOSL N/A
  • 52 Week Low
  • CSBR $3.60
  • FOSL $0.75
  • 52 Week High
  • CSBR $7.13
  • FOSL $1.74
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 51.57
  • FOSL 43.47
  • Support Level
  • CSBR $4.26
  • FOSL $1.25
  • Resistance Level
  • CSBR $4.70
  • FOSL $1.36
  • Average True Range (ATR)
  • CSBR 0.26
  • FOSL 0.12
  • MACD
  • CSBR 0.02
  • FOSL -0.01
  • Stochastic Oscillator
  • CSBR 64.86
  • FOSL 34.88

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

Share on Social Networks: